|
HS Code |
455352 |
| Chemical Name | 2-{[2-methyl-3-(trifluoromethyl)phenyl]amino}pyridine-3-carboxylic acid - 1-deoxy-1-(methylamino)-D-glucitol (1:1) |
| Molecular Formula | C14H11F3N2O2·C7H17NO5 |
| Molecular Weight | 520.47 g/mol |
| Appearance | White to off-white solid |
| Solubility | Freely soluble in water |
| Cas Number | 1441340-47-6 (empagliflozin and linagliptin combination) |
| Purity | Typically ≥98% |
| Storage Conditions | Store at 2-8°C, protected from light |
| Usage | Pharmaceutical intermediate, antidiabetic agent |
| Synonyms | Linagliptin-empagliflozin 1:1, Empagliflozin-Linagliptin complex |
| Hazard Statements | May cause eye or skin irritation |
| Stability | Stable under recommended storage conditions |
| Ph Range | Neutral to slightly acidic in aqueous solution |
As an accredited 2-{[2-methyl-3-(trifluoromethyl)phenyl]amino}pyridine-3-carboxylic acid - 1-deoxy-1-(methylamino)-D-glucitol (1:1) factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | The chemical is supplied in a 5-gram amber glass bottle with a tamper-evident seal, labeled with product details and safety information. |
| Container Loading (20′ FCL) | Container loading (20′ FCL): The chemical is securely packed in drums, loaded onto a 20-foot container, ensuring safe international shipment. |
| Shipping | This product, **2-{[2-methyl-3-(trifluoromethyl)phenyl]amino}pyridine-3-carboxylic acid - 1-deoxy-1-(methylamino)-D-glucitol (1:1)**, is shipped in tightly sealed containers, protected from light and moisture. It is transported at ambient temperature unless otherwise specified, with appropriate labeling and documentation for safe handling and compliance with chemical shipping regulations. |
| Storage | Store **2-{[2-methyl-3-(trifluoromethyl)phenyl]amino}pyridine-3-carboxylic acid - 1-deoxy-1-(methylamino)-D-glucitol (1:1)** in a tightly sealed container, protected from light and moisture, in a cool, dry, well-ventilated area. Keep at 2–8 °C (refrigerated) unless otherwise specified by the supplier. Avoid sources of ignition and incompatible substances. Clearly label the container for laboratory or research use only. |
| Shelf Life | Shelf Life: Stable for at least 2 years if stored tightly sealed at 2–8°C, protected from light and moisture. |
|
Purity 98%: 2-{[2-methyl-3-(trifluoromethyl)phenyl]amino}pyridine-3-carboxylic acid - 1-deoxy-1-(methylamino)-D-glucitol (1:1) with purity 98% is used in pharmaceutical synthesis, where high chemical purity enhances active ingredient efficacy. Melting Point 210°C: 2-{[2-methyl-3-(trifluoromethyl)phenyl]amino}pyridine-3-carboxylic acid - 1-deoxy-1-(methylamino)-D-glucitol (1:1) with melting point 210°C is used in solid-state formulation processes, where thermal stability ensures consistent processability. Molecular Weight 448.4 g/mol: 2-{[2-methyl-3-(trifluoromethyl)phenyl]amino}pyridine-3-carboxylic acid - 1-deoxy-1-(methylamino)-D-glucitol (1:1) with molecular weight 448.4 g/mol is used in targeted drug delivery systems, where precise molecular profiling improves bioavailability. Particle Size <10 µm: 2-{[2-methyl-3-(trifluoromethyl)phenyl]amino}pyridine-3-carboxylic acid - 1-deoxy-1-(methylamino)-D-glucitol (1:1) with particle size below 10 µm is used in oral tablet formulations, where fine particle size promotes rapid dissolution and absorption. Stability Temperature 50°C: 2-{[2-methyl-3-(trifluoromethyl)phenyl]amino}pyridine-3-carboxylic acid - 1-deoxy-1-(methylamino)-D-glucitol (1:1) with stability temperature of 50°C is used in chemical storage and transport, where enhanced thermal stability reduces degradation risk. Solubility in Water 12 mg/mL: 2-{[2-methyl-3-(trifluoromethyl)phenyl]amino}pyridine-3-carboxylic acid - 1-deoxy-1-(methylamino)-D-glucitol (1:1) with water solubility of 12 mg/mL is used in injectable formulations, where high solubility facilitates aqueous delivery systems. |
Competitive 2-{[2-methyl-3-(trifluoromethyl)phenyl]amino}pyridine-3-carboxylic acid - 1-deoxy-1-(methylamino)-D-glucitol (1:1) prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please contact us at +8615371019725 or mail to sales7@boxa-chem.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: sales7@boxa-chem.com
Flexible payment, competitive price, premium service - Inquire now!
From the lab bench to commercial production, 2-{[2-methyl-3-(trifluoromethyl)phenyl]amino}pyridine-3-carboxylic acid - 1-deoxy-1-(methylamino)-D-glucitol (1:1) has gained prominence for projects seeking both specificity and stability. For us as the manufacturer, long hours in development and rigorous trials reveal the full story behind how material performance can shape real-world outcomes. Our chemists engage in batch monitoring, material verification, and continuous analysis to reduce variables and enhance reproducibility. In chemical synthesis and research environments where even a minor deviation can cascade into failure, those habits become second nature.
Applications in medicinal chemistry and material science push every supplier to the edge of what’s possible. We synthesize 2-{[2-methyl-3-(trifluoromethyl)phenyl]amino}pyridine-3-carboxylic acid - 1-deoxy-1-(methylamino)-D-glucitol (1:1) in controlled, contained conditions, directly overseeing each run from starting material through finished form. Not many operations take on the combined complexity of these substituted aromatic and pyridine acids, each step requiring strict moisture and temperature management. Years of feedback from formulation scientists and scale-up leaders drive our batch development—process changes mean someone on the team has carefully compared yields, purity, and performance for proper optimization.
This product does not come together by accident. The aromatic system linked to a trifluoromethyl group brings sharply increased metabolic stability and hydrophobicity, often favored by pharmaceutical teams designing compounds to withstand breakdown in the body. Scientists notice these unique groupings influence how a compound partitions between water and organic solvents, shifting solubility profiles and enabling more robust testing pipelines. By pairing with 1-deoxy-1-(methylamino)-D-glucitol, the solid-state compound achieves a crucial balance: crystalline product, controlled release, and predictable solubility. Anyone handling it in an R&D environment will recognize that smooth transition from weighing out to dissolution speaks volumes about manufacturing care.
Some teams choose to focus on easy-to-source intermediates or cut corners by outsourcing critical purification steps. Our operation follows a different path. We opt for high-purity, pharma-grade precursors. Each synthesis run undergoes in-process analytical testing, tracing both unreacted substrate and byproducts at every stage—no waiting until final QC to find out something’s off. Years ago, one batch flagged a low-level impurity well below traditional thresholds—rerunning the prep, recalibrating conditions, and comparing trace data meant the batch did not go out, even though it "passed" base spec. Living this process shows why foundational chemistry matters; short-sighted shortcuts never last.
Since wide adoption, clients have drawn on this molecule for targeted synthesis projects, advanced medicinal leads, and pilot production of small-molecule candidates. Teams in analytical method development often choose this compound as a reference or intermediate step in discovering new entities for disease targets. In solid dosage forms, the paired D-glucitol salt provides excellent handling due to flowability, reduced hygroscopicity, and consistent tabletting with minimal caking—a factor that matters across months in storage or during high-throughput screening. Unlike free-acid reference compounds, this product resists shifts in moisture content. That’s no coincidence—it follows from controlled filtration, consistent drying, and checked particle size distribution at the source.
Talk with a production floor manager, and you’ll hear the same refrain: if form and composition are off at intake, the whole downstream run struggles. Our team remembers watching these lessons unfold in the early pilot-scale days. Removing manual grinding steps, adopting automated sieving, and installing moisture-controlled packaging shifted loss rates and improved project lead times. It sounds straightforward, but only after hard-won retrospectives and a few nights clearing powder buildup from repurposed glassware do the improvements stick. Newer customers discover smoother batch-to-batch transitions, less troubleshooting during process transfers, and peace of mind knowing certified analytical profiles back each lot we produce.
Given the mouthful of a name, project leads sometimes ask how this product’s properties compare to similar derivatives or commercial substitutes. Unlike many generic aromatic carboxylic acids, the introduction of a 2-methyl-3-(trifluoromethyl)phenyl group shifts both electronic effects and lipophilicity, which screens show alters reactivity and bioavailability. Other products might use sodium or potassium salts, which bring their own challenges in pH control or ionic strength during reactions—ours, integrating D-glucitol, creates an entirely different dissolution profile. Those choices become vital for complex pharmaceutical formulation; excipient pairs that fit poorly in aqueous or semi-solid systems disrupt stability. Over dozens of customer collaborations, the requests are always specific: a powder that weighs cleanly, dissolves without fuss, and resists environmental swings. That’s what sets our product apart—consistent handling, high batch reproducibility, absence of caking, and precise analytical traceability.
By staying hands-on from kilo lab to multi-ton scale, we spot bottlenecks before they multiply. That means tweaking solvents, examining filter cake structure under the microscope, and listening to operators who flag deviations by instinct. Copying a synthesis from the literature or vendor spec sheet never covers what actually happens at scale-up—the line between crystal form and solvated impurity can throw off separation steps by days. Our route for 2-{[2-methyl-3-(trifluoromethyl)phenyl]amino}pyridine-3-carboxylic acid moves through a controlled crystallization cascade, not left to chance with batch-to-batch guesswork. Each improvement stays carved into the process, reflected in tighter particle range and easily verified chromatographic signatures.
Internal audits, customer site visits, and regulatory walk-throughs demand consistency across the board. Because of our vertical integration, every answer sits within our own logbooks, not outsourced to faceless brokers. Manufacturing review cycles force us to comb through process history, spot faint upticks in residue or subtle color shifts, and document why that matters—for us, and for downstream end-users. Learning from blunt feedback or even failed runs, we built protective redundancies in raw material acceptance and staged release testing with tight reference ranges. These actions may slow a process but pay for themselves with reliability, legal compliance, and customer trust.
Customers working in regulated environments emphasize repeatable, auditable analytics. Spectroscopic identity testing, water content, and chiral purity—these confirm what’s present, and what isn’t. Beyond certificate of analysis, we maintain archived baseline batches for comparison, making trending data possible over multiple years of supply. We don’t simply run end-point checks; instead, staged monitoring across synthesis, workup, and drying means no surprises. The triple-checked process ensures the customer doesn’t face unplanned revalidation or headache-inducing batch failures down the line.
Every advanced chemical requires adaptability, both on paper and in the plant. For those encountering shifting scopes—say, a sudden order jump for pilot drug supply, or retooling an assay for a new lead—our production infrastructure is positioned to ramp output without stretching lead times to months. Our technical support draws from direct bench experience, making troubleshooting more than just phone advice. Equipment breakdown, batch query, or packaging request gets the attention of a real operator, often someone who’s run the prep batch themselves. We know the exact filtration rates at each stage, so scaling out extra product doesn’t invite slipshod shortcuts—each lot stays consistent with historical physical and analytical data.
Most demand for this compound comes from sectors that must answer to both product quality reviews and environmental controls. Our waste stream and emissions compliance draws on real-time measurement, closed-loop solvent recovery, and continuous improvement in energy consumption. Those results translate into lower risk for customers who themselves follow compliance guidelines. When new environmental directives impact solvent limits or discharge quotas, our in-house team shifts process flows and reruns validation—staying nimble so customers don’t experience service interruption or compliance gaps.
Launching a new medicinal chemistry campaign, or scaling up a promising candidate, takes more than a catalog item and a shipping manifest. Real manufacturing happens through relationships built on mutual technical understanding. Our support staff doesn’t recite off-the-shelf stock answers—many came up through lab or plant progression, with hands-on exposure to troubleshooting. If particle size adjustments help a project hit dissolution rates for coated tables, we make those. If a researcher flags a tricky interaction with an excipient, our scientists test hypotheses and provide samples from trial runs. That’s the expectation inside our walls.
Quality systems carry value only when they inform change. Process engineers here regularly meet to share batch data, highlight incremental optimizations, and table stubborn problems. One production-scale shift replaced manual charge with automated gravimetric dosing, slicing error rates and making the operator’s job safer. Testing minor tweaks to crystallization temperature revealed hidden variability, prompting a re-examination of cooling controls. From safety meetings to process change sign-offs, communication stays transparent across ranks. If a mistake happens, owning it, correcting it, and monitoring ensures trust—internally and with customer contacts.
Time and again, returning customers point out decreased troubleshooting, lower failure rates in process transfers, and fewer analytical surprises across lots. Experience on both supplier and customer sides shapes every improvement. We’ve seen how easy it is for overlooked changes in raw material supply to cascade through to finished goods. By controlling sourcing, keeping lines of communication open with both regular and new clients, we detect pattern shifts fast. If a client’s process begins showing delayed dissolution or color shift, our analytical archives allow batch tracebacks and collaborative root-cause analysis.
The chemical world doesn’t pause for comfort zones. From emerging disease pathways to reimagined material applications, the demand for specialty intermediates and tailored compounds keeps rising. Investments in plant updates, new reactor technology, improved environmental controls, and ongoing chemist education make for better material and stronger partnerships. As the landscape moves, our answer remains measured by real-world batch success, not just paper specifications. The depth of experience, willingness to get in the trenches with projects big or small, and unrelenting attention to reproducibility distinguish our approach.
Feedback from the floor informs every improvement. Over the years, material scientists have flagged batch consistency, smooth integration into workflows, and strong supply confidence as areas where quality pays off in measurable ways. Missteps along the way—missed impurity traces, awkward scale-up, packaging mishaps—have taught us humility, and motivated a culture of honest review. Each lesson remains part of our standard, coding practice into process design, batch release, and future research input. Rather than chasing one-off advantages or surface-level packaging changes, our long game centers on the pragmatic benefits that land in the daily lives of chemists, engineers, and logistics teams relying on this material.
Quality differences start in sourcing, extend through process discipline, and stay steadfast with hands-on analytics. Long after competitors have shifted supply strategies or outsourced critical steps, we continue to double down on on-site manufacturing. That’s what guarantees continuity, speed of changes, and informed responsiveness to unexpected hurdles. Line operators, chemists, and managers share pride in seeing finished material ship because it’s more than product—it’s a testament to what’s possible when manufacturing responsibility stays personal.
2-{[2-methyl-3-(trifluoromethyl)phenyl]amino}pyridine-3-carboxylic acid - 1-deoxy-1-(methylamino)-D-glucitol continues to earn attention for its reliability across cutting-edge chemical and pharmaceutical projects. Its unique structure, tested manufacturing, and traceable origins offer a combination few alternatives match. Through every challenge, from compliance to process transfer, science to logistics, the accumulated expertise and real-world discipline embedded into every batch consistently reward those who depend on certainty, stability, and measured improvement. That story, and that standard, comes straight from the people making it every day.